Several studies have used leptin gene transfer to treat diet-induced and age-related obesity and non-insulin-dependent diabetes mellitus (NIDDM) using animal models [25,31,32]; however, little work has been carried out in insulin-dependent diabetes mellitus and neuroendocrine alterations. Here, LEP is linked to type 1 diabetes mellitus.